Gentle automation for single-cell cloning and CRISPR-Cas9 editing in iPSCs
Clone iPSCs from single cells with 95% viability; Screen gene-edited hESCs at scale; Perform single-cell omics with high cell survival; Accelerate antibody discovery through efficient cloning; Enable monoclonality verification in stem cell lines
Trusted by University of Bonn, University of Oxford, IRBM; High cell viability reported in customer testimonials; Services used for gene editing and cloning in iPSCs; Low-volume cell culture chambers support nanolitre operations; Offers guide RNA design tool for CRISPR applications